B-cell infiltrates induce endosteal bone formation in inflammatory arthritis

Journal of Bone and Mineral Research

Volumn 23, Issue 10, 2008, Pages 1650-1660

  Hayer, Silvia ^a   Polzer, Karin ^a,b   Brandl, Andreas ^c   Zwerina, Jochen ^b   Kireva, Trayana ^b   Smolen, Josef S ^a   Schett, Georg ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Arthritis animal model; B cells; Bone marrow inflammation; Osteoblasts

Indexed keywords

ANTIGEN; AUTOANTIBODY; IMMUNOGLOBULIN; OSTEOGENIC PROTEIN 1; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCING CELL; ARTHRITIS; ARTICLE; B LYMPHOCYTE; BONE EROSION; BONE MARROW; CELL INFILTRATION; CELL MATURATION; CONTROLLED STUDY; CORTICAL BONE; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; OSSIFICATION; PROTEIN EXPRESSION; SYNOVIUM; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; BASE SEQUENCE; BONE DEVELOPMENT; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION;

EID: 52949152369     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.080508     Document Type: Article

References (24)

1. Scott DL, Smith C, Kingsley G 2003 Joint damage and disability in rheumatoid arthritis: An updated systematic review. Clin Exp Rheumatol 21:20-27.
2. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR 1998 Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943-951.
3. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, Steiner G, Smolen JS, Wagner EF, Schett G 2002 Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest 110:1419-1427.
4. Li P, Schwarz EM, O'Keefe RJ, Ma L, Boyce BF, Xing L 2004 RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. J Bone Miner Res 19:207-213.
5. Jimenez-Boj E, Redlich K, Turk B, Hanslik-Schnabel B, Wanivenhaus A, Chott A, Smolen JS, Schett G 2005 Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. J Immunol 175:2579-2588.
6. Bugatti S, Caporali R, Manzo A, Vitolo B, Pitzalis C, Montecucco C 2005 Involvement of subchondral bone marrow in rheumatoid arthritis: Lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment. Arthritis Rheum 52:3448-3459.
7. Appel H, Kuhne M, Spiekermann S, Ebhardt H, Grozdanovic Z, Kohler D, Dreimann M, Hempfing A, Rudwaleit M, Stein H, Metz-Stavenhagen P, Sieper J, Loddenkemper C 2006 Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 54:2845-2851.
8. Gortz B, Hayer S, Redlich K, Zwerina J, Tohidast-Akrad M, Tuerk B, Hartmann C, Kollias G, Steiner G, Smolen JS, Schett G 2004 Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation. J Bone Miner Res 19:990-998.
9. Silverman GJ, Carson DA 2003 Roles of B cells in rheumatoid arthritis. Arthritis Res Ther 5(Suppl 4):S1-S6.
10. Browning JL 2006 B cells move to centre stage: Novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov 5:564-576.
11. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G 1991 Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J 10:4025-4031.
12. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S 1993 Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279-290.
13. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Copeland NG 1993 Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358-361.
14. Satterthwaite AB, Witte ON 2000 The role of Bruton's tyrosine kinase in B-cell development and function: A genetic perspective. Immunol Rev 175:120-127.
15. Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O'Fallon WM, Goronzy JJ, Weyand CM 2001 Lymphoid neogenesis in rheumatoid synovitis. J Immunol 167:1072-1080.
16. Schett G, Hayer S, Zwerina J, Redlich K, Smolen JS 2005 Mechanisms of Disease: The link between RANKL and arthritic bone disease. Nat Clin Pract Rheumatol 1:47-54.
17. Hayer S, Tohidast-Akrad M, Haralambous S, Jahn-Schmid B, Skriner K, Trembleau S, Dumortier H, Pinol-Roma S, Redlich K, Schett G, Muller S, Kollias G, Smolen J, Steiner G 2005 Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice. J Immunol 175:8327-8336.
18. Steiner G, Skriner K, Smolen JS 1996 Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: Novel tools for the diagnosis of rheumatic diseases, Int Arch Allergy Immunol 111:314-319.
19. Fritsch R, Eselbock D, Skriner K, Jahn-Schmid B, Scheinecker C, Bohle B, Tohidast-Akrad M, Hayer S, Neumuller J, Pinol-Roma S, Smolen JS, Steiner G 2002 Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis. J Immunol 169:1068-1076.
20. Chen D, Zhao M, Mundy GR 2004 Bone morphogenetic proteins. Growth Factors 22:233-241.
21. Vukicevic S, Kopp JB, Luyten FP, Sampath TK 1996 Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc Natl Acad Sci USA 93:9021-9026.
22. Huch K, Wilbrink B, Flechtenmacher J, Koepp HE, Aydelotte MB, Sampath TK, Kuettner KE, Mollenhauer J, Thonar EJ 1997 Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1beta. Arthritis Rheum 40:2157-2161.
23. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T 2004 Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350:2572-2581.
24. Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, Racewicz AJ, van Vollenhoven RF, Li NF, Agarwal S, Hessey EW, Shaw TM; DANCER Study Group. 2006 The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum 54:1390-1400.